Benjamin Looker serves as Executive at Esperion Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Benjamin Looker has executed 9 insider transactions totaling $92.3K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 17, 2025 involved selling 6,517 shares valued at $23.9K.
Benjamin Looker currently holds 385,905 shares of Esperion Therapeutics, Inc. (ESPR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Benjamin Looker has been a net seller of ESPR stock. They have purchased $0 and sold $92.3K worth of shares.
Benjamin Looker's most recent insider trade was on Dec 17, 2025, when they sold 6,517 shares at $3.67 per share.
Get notified when new Form 4 filings are submitted
| $2.62 |
| Discretionary |
| Sep 17, 2025 | ESPR | $17.5K | Sale | 6,267 | $2.80 | Discretionary |
| Jul 17, 2025 | ESPR | $1.5K | Sale | 1,304 | $1.13 | Discretionary |
| Mar 14, 2024 | ESPR | $0 | Award | 100,000 | $N/A | Discretionary |
| Apr 19, 2023 | ESPR | $1.6K | Sale | 1,290 | $1.27 | Discretionary |
| Mar 14, 2023 | ESPR | $0 | Award | 20,500 | $N/A | Discretionary |
| Jan 18, 2023 | ESPR | $44.4K | Sale | 6,347 | $7.00 | Discretionary |
| Jan 27, 2022 | ESPR | $0 | Award | 70,800 | $N/A | Discretionary |